• Sun. Jun 16th, 2024

LevelJump Healthcare Is On The Move…This Is Just The Beginning

A few weeks ago, we highlighted LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) as an emerging growth story that is flying under the radar.

We hope you followed through on the opportunity as the stock has been steadily trending higher. During the last month, the stock has rallied more than 60% and we believe this is just the beginning. LevelJump is executing on a multi-faceted growth strategy and we are bullish on the direction the business is heading.

An Undervalued Business With Catalysts For Growth 

LevelJump represents a unique growth story and we consider the opportunity to be differentiated from other telehealth companies. The company provides telehealth solutions to client hospitals and imaging centers through its teleradiology division. The firm also offers in person radiology services through its IHF’s (Independent Healthcare Facilities). 

LevelJump focuses primarily on providing critical care services for urgent and emergency patients and is working to establish integral relationships in the communities it operates in. We are favorable on the organic and inorganic growth strategy that is associated with the business and believe the business is positioned to record strong growth in 2023 and beyond.

Currently, LevelJump operates 3 IHFs which provide x-ray, ultrasound and mammography scans directly to patients. The company is in the process of constructing a new multi-modality IHF in central Toronto (expected to open in the second quarter of 2023) and we expect the development to serve as a growth catalyst.

LevelJump provides all of its services through its wholly-owned subsidiary, Canadian Teleradiology Services (CTS). Currently, CTS provides services to more than three dozen Canadian hospitals and clinics. The business provides solutions that assist understaffed hospitals, overworked radiology groups, and shortages in emergency care. 

An Execution Story To Be Aware Of

We believe the management team is executing on a calculated growth strategy and are favorable on the risk-reward profile that is associated with the business. We have analyzed a number of telehealth companies and only few have been able to return value to shareholders. We believe that LevelJump is led by a management team that cares about its investors and consider this to be a very important trait of the company.

At current levels, LevelJump is trading for less than 1x revenue and we expect this to change over the next year. As the management team continues to execute, we believe the stock will attract more attention and want our readers to be aware of it. 

We consider LevelJump to be a company that has significant potential growth catalysts and believe the market is undervaluing the business. From the growing IHF footprint to the new radiology contracts, the company is well positioned to capitalize on a burgeoning market and we are favorable on how the management team is executing. 

Company Relationship Disclosure

OTB is responsible for the OTB opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and OTB does not undertake to confirm or substantiate or be responsible for such information provided by other parties.

Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.

Pursuant to an agreement between Spotlight Media and LevelJump Healthcare we have been hired for a period of 30 days beginning April 10, 2023 and ending May 10, 2023 to publicly disseminate information about LevelJump Healthcare including on the Website and other media including Facebook and Twitter. We are being paid $3,500 per month by LevelJump Healthcare and were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of LevelJump Healthcare that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of LevelJump Healthcare in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign up for OnTheBid Insights - Insights you can read in 2 minutes or less

Catch TRENDS instead of missed opportunities. We'll get you On The Bid.